Infectious disease 2001: drug resistance, new drugs.
The 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) was held in Chicago on 16-19 December 2001, rescheduled following the tragic events of 11th September. Nonetheless, it attracted thousands of delegates from industry and academia and covered, in over 2200 oral and poster presentations, topics ranging from bioterrorism, microbial pathogenesis and emerging pathogens, to infection control, vaccines, antibiotic resistance and new antimicrobial agents and treatment strategies. Summarized here are highlights on bacterial and fungal drug resistance and on new agents in preclinical and clinical development.
Georgopapadakou
Nafsika H
NH
NewBiotics, Inc, 4939 Directors Place, San Diego, CA 92121-3829, USA. nafsikag@aol.com
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003141:Communicable Diseases / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial / Q000502:physiology*; D025141:Drug Resistance, Fungal / Q000502:physiology*; D006801:Humans
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents